ORIC · Oric Pharmaceuticals, Inc.

$13.91 +0.08 (+0.58%) At close · Aug 26

Market Cap

$1.44B

103.65M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$657,500	—	$826,000	$3,634,560	$434,000	$15,104	$5,567,164
Pratik Multani	Chief Medical Officer	$513,333	—	$280,840	$1,226,664	$246,500	$15,104	$2,282,441
Dominic Piscitelli	Chief Financial Officer	$482,917	—	$280,840	$1,226,664	$231,900	$15,104	$2,237,425

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$627,333	—	$776,900	$3,466,878	$396,800	$14,904	$5,282,815
Pratik Multani	Chief Medical Officer	$493,583	—	$274,200	$1,223,604	$227,100	$14,904	$2,233,391
Dominic Piscitelli	Chief Financial Officer	$458,083	—	$274,200	$1,223,604	$210,800	$15,272	$2,181,959

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$596,083	—	$396,000	$1,796,080	$350,200	$14,720	$3,153,083
Pratik Multani	Chief Medical Officer	$476,500	—	$144,000	$651,079	$224,000	$14,720	$1,510,299
Dominic Piscitelli	Chief Financial Officer	$435,584	—	$144,000	$651,079	$204,800	$14,358	$1,449,821

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$572,103	—	$474,000	$2,970,009	$336,110	$13,108	$4,365,330
Dominic Piscitelli	Chief Financial Officer	$418,348	—	$171,825	$1,110,821	$196,623	$21,942	$1,919,559
Pratik Multani	Chief Medical Officer	$458,349	—	$171,825	$1,050,296	$215,424	$13,108	$1,909,002

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$536,278	—	—	$6,092,240	$335,200	$12,206	$6,975,924
Pratik Multani	Chief Medical Officer	$438,352	—	—	$1,958,220	$219,200	$12,206	$2,627,978
Dominic Piscitelli	Chief Financial Officer	$398,518	—	—	$1,958,220	$199,300	$12,206	$2,568,244

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$489,167	—	—	$5,082,831	$300,800	$988	$5,873,786
Pratik Multani	Chief Medical Officer	$416,667	—	—	$1,713,640	$205,000	$621	$2,335,928
Dominic Piscitelli	Chief Financial Officer	$380,833	—	—	$1,002,044	$187,400	$606	$1,570,883

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dominic Piscitelli	Chief Financial Officer	$115,144	—	—	$1,083,150	$38,300	$111	$1,236,705
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$455,833	—	—	—	$194,900	$21,396	$672,129
Pratik Multani	Chief Medical Officer	$398,333	—	—	—	$132,400	$4,423	$535,156

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jacob M. Chacko, M.D.	President and Chief Executive Officer	$290,000	—	—	$1,194,442	$92,800	$57,897	$1,635,139
Pratik Multani	Chief Medical Officer	$112,500	—	—	$324,768	$27,000	$25,876	$490,144
Dominic Piscitelli	Chief Financial Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Mardi C. Dier	Class III director	Appointed	2026-06-18	2026-06-22
Jacob M. Chacko, M.D.	Class III director	Appointed	2026-06-18	2026-06-22
Angie You, Ph.D.	Class II director	Appointed	2021-11-09	2021-11-10
Carl Gordon, Ph.D., C.F.A.	director	Resigned	2021-11-09	2021-11-10
Steven L. Hoerter	Board of Directors	Appointed	2021-08-16	2021-08-16
Steven L. Hoerter	Class II director	Appointed	2021-08-13	2021-08-16
Peter Svennilson	director	Resigned	2021-08-13	2021-08-16
Lori Kunkel	Class I director	Appointed	2020-06-09	2020-06-10

Key facts CIK 1796280 CUSIP 68622P109 13F (30d) 165 filings 165 filers Visit website Investor relations